236 related articles for article (PubMed ID: 31015807)
1. Pre-clinical development of a vaccine against Lassa fever.
Banadyga L; Stein DR; Qiu X; Safronetz D
Can Commun Dis Rep; 2018 Jun; 44(6):139-147. PubMed ID: 31015807
[TBL] [Abstract][Full Text] [Related]
2. A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses.
Safronetz D; Mire C; Rosenke K; Feldmann F; Haddock E; Geisbert T; Feldmann H
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003736. PubMed ID: 25884628
[TBL] [Abstract][Full Text] [Related]
3. A Lassa Virus Live-Attenuated Vaccine Candidate Based on Rearrangement of the Intergenic Region.
Cai Y; Iwasaki M; Motooka D; Liu DX; Yu S; Cooper K; Hart R; Adams R; Burdette T; Postnikova EN; Kurtz J; St Claire M; Ye C; Kuhn JH; Martínez-Sobrido L; de la Torre JC
mBio; 2020 Mar; 11(2):. PubMed ID: 32209677
[TBL] [Abstract][Full Text] [Related]
4. Current research for a vaccine against Lassa hemorrhagic fever virus.
Warner BM; Safronetz D; Stein DR
Drug Des Devel Ther; 2018; 12():2519-2527. PubMed ID: 30147299
[TBL] [Abstract][Full Text] [Related]
5. Vaccine platforms to control Lassa fever.
Lukashevich IS; Pushko P
Expert Rev Vaccines; 2016 Sep; 15(9):1135-50. PubMed ID: 27136941
[TBL] [Abstract][Full Text] [Related]
6. PROSPECTS OF LASSA FEVER CANDIDATE VACCINES.
Isaac AB; Karolina W; Temitope AA; Anuska R; Joanne E; Deborah A; Bianca OC; Filip T; Zofia P; Oluwasegun OI; Oluwaferanmi O; Grace BT
Afr J Infect Dis; 2022; 16(2 Suppl):46-58. PubMed ID: 36124324
[TBL] [Abstract][Full Text] [Related]
7. A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa fever.
Cross RW; Woolsey C; Prasad AN; Borisevich V; Agans KN; Deer DJ; Geisbert JB; Dobias NS; Fenton KA; Geisbert TW
Cell Rep; 2022 Jul; 40(3):111094. PubMed ID: 35858566
[TBL] [Abstract][Full Text] [Related]
8. Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs.
Maruyama J; Mateer EJ; Manning JT; Sattler R; Seregin AV; Bukreyeva N; Jones FR; Balint JP; Gabitzsch ES; Huang C; Paessler S
Vaccine; 2019 Oct; 37(45):6824-6831. PubMed ID: 31561999
[TBL] [Abstract][Full Text] [Related]
9. Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development.
Hallam HJ; Hallam S; Rodriguez SE; Barrett ADT; Beasley DWC; Chua A; Ksiazek TG; Milligan GN; Sathiyamoorthy V; Reece LM
NPJ Vaccines; 2018; 3():11. PubMed ID: 29581897
[TBL] [Abstract][Full Text] [Related]
10. Hexestrol, an estrogen receptor agonist, inhibits Lassa virus entry.
Zhang Z; Takenaga T; Fehling SK; Igarashi M; Hirokawa T; Muramoto Y; Yamauchi K; Onishi C; Nakano M; Urata S; Groseth A; Strecker T; Noda T
J Virol; 2024 May; ():e0071424. PubMed ID: 38809021
[TBL] [Abstract][Full Text] [Related]
11. Lassa virus diversity and feasibility for universal prophylactic vaccine.
Lukashevich IS; Paessler S; de la Torre JC
F1000Res; 2019; 8():. PubMed ID: 30774934
[TBL] [Abstract][Full Text] [Related]
12. Construction and Immunological Evaluation of an Adenoviral Vector-Based Vaccine Candidate for Lassa Fever.
Wang M; Li R; Li Y; Yu C; Chi X; Wu S; Liu S; Xu J; Chen W
Viruses; 2021 Mar; 13(3):. PubMed ID: 33804206
[TBL] [Abstract][Full Text] [Related]
13. Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot.
Mateo M; Reynard S; Carnec X; Journeaux A; Baillet N; Schaeffer J; Picard C; Legras-Lachuer C; Allan R; Perthame E; Hillion KH; Pietrosemoli N; Dillies MA; Barrot L; Vallve A; Barron S; Fellmann L; Gaillard JC; Armengaud J; Carbonnelle C; Raoul H; Tangy F; Baize S
Sci Transl Med; 2019 Oct; 11(512):. PubMed ID: 31578242
[TBL] [Abstract][Full Text] [Related]
14. The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.
Safronetz D; Rosenke K; Westover JB; Martellaro C; Okumura A; Furuta Y; Geisbert J; Saturday G; Komeno T; Geisbert TW; Feldmann H; Gowen BB
Sci Rep; 2015 Oct; 5():14775. PubMed ID: 26456301
[TBL] [Abstract][Full Text] [Related]
15. Lethal Infection of Lassa Virus Isolated from a Human Clinical Sample in Outbred Guinea Pigs without Adaptation.
Maruyama J; Manning JT; Mateer EJ; Sattler R; Bukreyeva N; Huang C; Paessler S
mSphere; 2019 Sep; 4(5):. PubMed ID: 31554720
[TBL] [Abstract][Full Text] [Related]
16. Attenuated Replication of Lassa Virus Vaccine Candidate ML29 in STAT-1
Johnson DM; Jokinen JD; Lukashevich IS
Pathogens; 2019 Jan; 8(1):. PubMed ID: 30650607
[TBL] [Abstract][Full Text] [Related]
17. Routine and pulse vaccination for Lassa virus could reduce high levels of endemic disease: A mathematical modelling study.
Davies J; Lokuge K; Glass K
Vaccine; 2019 Jun; 37(26):3451-3456. PubMed ID: 31088745
[TBL] [Abstract][Full Text] [Related]
18. Combating Lassa Fever in West African Sub-Region: Progress, Challenges, and Future Perspectives.
Aloke C; Obasi NA; Aja PM; Emelike CU; Egwu CO; Jeje O; Edeogu CO; Onisuru OO; Orji OU; Achilonu I
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680186
[TBL] [Abstract][Full Text] [Related]
19. Meeting report: WHO consultation on accelerating Lassa fever vaccine development in endemic countries, Dakar, 10-11 September 2019.
Salami K; Gsell PS; Olayinka A; Maiga D; Formenty P; Smith PG; Moorthy V
Vaccine; 2020 May; 38(26):4135-4141. PubMed ID: 31952873
[TBL] [Abstract][Full Text] [Related]
20. A recombinant vesicular stomatitis-based Lassa fever vaccine elicits rapid and long-term protection from lethal Lassa virus infection in guinea pigs.
Stein DR; Warner BM; Soule G; Tierney K; Frost KL; Booth S; Safronetz D
NPJ Vaccines; 2019; 4():8. PubMed ID: 30774999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
